SG11201502149YA - Coumarin derivative - Google Patents
Coumarin derivativeInfo
- Publication number
- SG11201502149YA SG11201502149YA SG11201502149YA SG11201502149YA SG11201502149YA SG 11201502149Y A SG11201502149Y A SG 11201502149YA SG 11201502149Y A SG11201502149Y A SG 11201502149YA SG 11201502149Y A SG11201502149Y A SG 11201502149YA SG 11201502149Y A SG11201502149Y A SG 11201502149YA
- Authority
- SG
- Singapore
- Prior art keywords
- coumarin derivative
- coumarin
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/12—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012208656 | 2012-09-21 | ||
PCT/JP2013/075414 WO2014046224A1 (en) | 2012-09-21 | 2013-09-20 | Coumarin derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201502149YA true SG11201502149YA (en) | 2015-05-28 |
Family
ID=50341526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201502149YA SG11201502149YA (en) | 2012-09-21 | 2013-09-20 | Coumarin derivative |
Country Status (15)
Country | Link |
---|---|
US (1) | US9365533B2 (en) |
EP (1) | EP2899187B1 (en) |
JP (1) | JP6091016B2 (en) |
KR (1) | KR20150056544A (en) |
CN (1) | CN104640849B (en) |
AU (1) | AU2013318962B2 (en) |
BR (1) | BR112015005973A2 (en) |
CA (1) | CA2885262A1 (en) |
ES (1) | ES2630068T3 (en) |
HK (1) | HK1211918A1 (en) |
IL (1) | IL237823A (en) |
RU (1) | RU2646756C2 (en) |
SG (1) | SG11201502149YA (en) |
TW (1) | TWI583677B (en) |
WO (1) | WO2014046224A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106232116B (en) * | 2014-03-20 | 2020-05-01 | 日本脏器制药株式会社 | Therapeutic or prophylactic agent comprising coumarin derivative as active ingredient |
JP6089055B2 (en) * | 2014-03-20 | 2017-03-01 | 日本臓器製薬株式会社 | Pharmaceuticals containing coumarin derivatives |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1523317A (en) * | 1967-03-20 | 1968-05-03 | Lipha | New hydroxylated derivatives of coumarin and their preparation processes |
FR2543140B1 (en) * | 1983-03-24 | 1985-06-21 | Cortial | NOVEL FLAVONE-CARBOXYLIC ACIDS-4 ', THEIR PREPARATION METHOD AND THEIR APPLICATION IN THERAPEUTICS |
RU2036917C1 (en) * | 1989-11-28 | 1995-06-09 | Санкио Компани Лимитед | Coumarin derivatives or their pharmaceutically acceptable salt |
CA2089372A1 (en) * | 1990-09-28 | 1993-03-25 | Pharmacia & Upjohn Company | Anthelmintic and anticoccidial 3-carbamoyl-4-hydroxycoumarins, method of use and compositions |
US5922755A (en) | 1993-04-09 | 1999-07-13 | Toyama Chemical Co., Ltd. | Immunomodulator, cell adhesion inhibtor, and agent for treating, and preventing autoimmune diseases |
EP0807629B1 (en) * | 1996-05-15 | 2004-03-03 | Aventis Pharma Deutschland GmbH | Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them |
US6191164B1 (en) * | 1996-05-15 | 2001-02-20 | Hoechst Aktiengesellschaft | Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
JP4658512B2 (en) * | 2004-04-27 | 2011-03-23 | 日本臓器製薬株式会社 | Coumarin derivative and Maillard reaction inhibitor containing the derivative |
DE102004063910B4 (en) * | 2004-07-05 | 2006-12-28 | Bioplanta Arzneimittel Gmbh | Trisubstituted benzopyranones and plant extracts and compositions containing them |
WO2009014100A1 (en) * | 2007-07-20 | 2009-01-29 | Chugai Seiyaku Kabushiki Kaisha | p27 PROTEIN INDUCER |
-
2013
- 2013-09-18 TW TW102133808A patent/TWI583677B/en not_active IP Right Cessation
- 2013-09-20 US US14/429,300 patent/US9365533B2/en active Active
- 2013-09-20 AU AU2013318962A patent/AU2013318962B2/en not_active Ceased
- 2013-09-20 RU RU2015114480A patent/RU2646756C2/en not_active IP Right Cessation
- 2013-09-20 ES ES13838182.7T patent/ES2630068T3/en active Active
- 2013-09-20 WO PCT/JP2013/075414 patent/WO2014046224A1/en active Application Filing
- 2013-09-20 SG SG11201502149YA patent/SG11201502149YA/en unknown
- 2013-09-20 CN CN201380048855.5A patent/CN104640849B/en active Active
- 2013-09-20 EP EP13838182.7A patent/EP2899187B1/en active Active
- 2013-09-20 CA CA2885262A patent/CA2885262A1/en not_active Abandoned
- 2013-09-20 JP JP2014536924A patent/JP6091016B2/en active Active
- 2013-09-20 KR KR1020157006140A patent/KR20150056544A/en active IP Right Grant
- 2013-09-20 BR BR112015005973A patent/BR112015005973A2/en not_active IP Right Cessation
-
2015
- 2015-03-19 IL IL237823A patent/IL237823A/en active IP Right Grant
- 2015-12-23 HK HK15112624.2A patent/HK1211918A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW201418239A (en) | 2014-05-16 |
RU2015114480A (en) | 2016-11-10 |
JPWO2014046224A1 (en) | 2016-08-18 |
ES2630068T3 (en) | 2017-08-17 |
TWI583677B (en) | 2017-05-21 |
US20150232440A1 (en) | 2015-08-20 |
CA2885262A1 (en) | 2014-03-27 |
US9365533B2 (en) | 2016-06-14 |
WO2014046224A1 (en) | 2014-03-27 |
BR112015005973A2 (en) | 2017-07-04 |
EP2899187B1 (en) | 2017-04-19 |
CN104640849A (en) | 2015-05-20 |
JP6091016B2 (en) | 2017-03-08 |
AU2013318962A1 (en) | 2015-04-16 |
RU2646756C2 (en) | 2018-03-07 |
HK1211918A1 (en) | 2016-06-03 |
EP2899187A4 (en) | 2016-06-29 |
IL237823A (en) | 2017-05-29 |
CN104640849B (en) | 2016-10-26 |
EP2899187A1 (en) | 2015-07-29 |
KR20150056544A (en) | 2015-05-26 |
AU2013318962B2 (en) | 2017-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2200040I1 (en) | Benzimidazole-proline derivatives | |
HK1205740A1 (en) | Pyrrolotriazinone derivatives | |
HK1207375A1 (en) | Piperidinylpyrazolopyridine derivative | |
HK1207363A1 (en) | Novel indanesulfamide derivative | |
AP2015008347A0 (en) | Oxazolidin-2-one-pyrimidine derivatives | |
HK1208817A1 (en) | Chromane compounds | |
HK1200824A1 (en) | Substituted phenylazole derivative | |
HK1197062A1 (en) | Chromene compound | |
PT2873660T (en) | Indolecarboxamide derivative | |
EP2821404A4 (en) | Chroman derivative | |
EP2842958A4 (en) | Naphthobisthiadiazole derivative | |
SG11201404325VA (en) | Pyrimidooxazocine derivatives as mtor - inhibitors | |
HK1211918A1 (en) | Coumarin derivative | |
HK1204621A1 (en) | 4-alkanoylamino-3-pyrazolone derivative 4--3- |